MedPath

VeriGraft AB

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Tissue Engineered Veins in Patients With Chronic Venous Insufficiency

Phase 1
Recruiting
Conditions
Chronic Venous Insufficiency
Interventions
Drug: P-TEV
First Posted Date
2018-12-21
Last Posted Date
2023-10-04
Lead Sponsor
Verigraft AB
Target Recruit Count
15
Registration Number
NCT03784131
Locations
🇪🇸

Junta de Andalusia, Sevilla, Spain

© Copyright 2025. All Rights Reserved by MedPath